The mechanisms by which endothelium attenuates vasodilatation caused by isoflurane are not well understood. We examined the role of endothelium-derived substances, nitric oxide (NO), endothelium-derived hyperpolarizing factors (EDHF), prostanoids and endothelins in the response to isoflurane in rat thoracic aorta. Increasing cumulative concentrations of isoflurane were administered to aortic rings suspended in Hepes solution and preconstricted with either phenylephrine 10 Endothelium attenuated isofluraneinduced vasodilatation in KCl-constricted rings at concentrations of 4% (mean 95 (SEM 4) % vs 72 (4) %; P:0.0005) and 5% (100 (4) % vs 80 (4) %; P:0.0008) and in phenylephrine constricted rings at concentrations of 4% (54 (8) % vs 35 (3) %; P:0.04) and 5% (78 (10) % vs 49 (5) %; P:0.03). Relaxation was significantly greater in rings treated with LNNA than in intact rings at concentrations of 4% (85 (4) % vs 72 (4) %; P:0.0005) and 5% (90 (4) % vs 80 (4) %; P:0.0008). Indomethacin and BQ 123 did not alter isofluraneinduced vasodilatation. We conclude that endothelium attenuated the vasodilator effect of isoflurane by a mechanism which was abolished by inhibition of nitric oxide. We hypothesize that isoflurane inhibits the release of nitric oxide, leading to a relative vasoconstriction counterbalancing its vasodilator effect. In contrast, EDHF, prostanoids and endothelins were not involved in the attenuation of isoflurane-induced vasodilatation. (Br. J. Anaesth. 1997; 79: 84-87 Isoflurane is a volatile anaesthetic which relaxes vascular smooth muscle cells.
The mechanisms by which endothelium attenuates vasodilatation caused by isoflurane are not well understood. We examined the role of endothelium-derived substances, nitric oxide (NO), endothelium-derived hyperpolarizing factors (EDHF), prostanoids and endothelins in the response to isoflurane in rat thoracic aorta. Increasing cumulative concentrations of isoflurane were administered to aortic rings suspended in Hepes solution and preconstricted with either phenylephrine 10 Endothelium attenuated isofluraneinduced vasodilatation in KCl-constricted rings at concentrations of 4% (mean 95 (SEM 4) % vs 72 (4) %; P:0.0005) and 5% (100 (4) % vs 80 (4) %; P:0.0008) and in phenylephrine constricted rings at concentrations of 4% (54 (8) % vs 35 (3) %; P:0.04) and 5% (78 (10) % vs 49 (5) %; P:0.03). Relaxation was significantly greater in rings treated with LNNA than in intact rings at concentrations of 4% (85 (4) % vs 72 (4) %; P:0.0005) and 5% (90 (4) % vs 80 (4) %; P:0.0008). Indomethacin and BQ 123 did not alter isofluraneinduced vasodilatation. We conclude that endothelium attenuated the vasodilator effect of isoflurane by a mechanism which was abolished by inhibition of nitric oxide. We hypothesize that isoflurane inhibits the release of nitric oxide, leading to a relative vasoconstriction counterbalancing its vasodilator effect. Isoflurane is a volatile anaesthetic which relaxes vascular smooth muscle cells. [1] [2] [3] [4] [5] [6] [7] It has been shown previously that vessels without endothelium relaxed more than vessels with endothelium, 4 7 suggesting that isoflurane may either decrease the release of endothelium-derived relaxing factors or increase the release of endothelium-derived contracting factors. A previous study examined the role of nitric oxide (an endothelium-derived relaxing factor) and found that relaxation was comparable between denuded vessels and vessels treated with an inhibitor of nitric oxide synthase. 7 It has also been shown that the release of nitric oxide was decreased by volatile anaesthetics [8] [9] [10] [11] [12] [13] [14] [15] suggesting that nitric oxide accounts for the lesser degree of relaxation obtained in intact vessels compared with denuded vessels.
Even if nitric oxide is responsible for this effect, isoflurane may also inhibit the release of other endothelium-derived vasodilators (i.e. prostacyclin and endothelium-derived hyperpolarizing factors (EDHF)) or may increase the release of endothelium-derived vasoconstrictors (i.e. endothelins and thromboxane A 2 ). It has been shown recently that prostanoids and EDHF were decreased by isoflurane, 16 17 but their role in modulating the action of volatile anaesthetics on the intact vessel has not been investigated. In addition, interactions between isoflurane and release of endothelins by vessels have not been examined.
The aim of this study was to examine the role of nitric oxide, prostanoids, EDHF and endothelins in the modulation of relaxation induced by isoflurane in isolated rat thoracic aorta.
Materials and methods

ANIMALS
We used male Sprague-Dawley rats (300-350 g) (Iffa-Credo, France). The study was approved by the French Agriculture Office in conformity with European Legislation Involving Animals.
PREPARATION OF AORTIC RINGS
Animals were anaesthetized with pentobarbitone 50 mg kg 91 i.p., which does not alter the reactivity of vessels removed from these animals. 18 The thoracic aorta was removed and placed in modified Hepes buffer (37 ЊC) aerated with a mixture of 95% oxygen and 5% carbon dioxide. Aorta were dissected clean of fat and extraneous tissues and divided into 3.5-4.0-mm ring segments. In some rings, endothelium was removed mechanically by gently rubbing the intimal surface with a stainless steel rod. The rings were suspended between two L-shaped stainless steel hooks and placed in a 10-ml, waterjacketed organ chamber containing a solution composed of (mmol litre 91 ) NaCl 118.2, KCl 4.7, NaHCO 3 25.0, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 2.5, glucose 11.1 and Hepes 5. Organ chambers were aerated continuously with 95% oxygen and 5% carbon dioxide with pH maintained at 7.35-7.40. 19 Temperature was maintained constant at 37 ЊC. Isometric tensions were measured (g) using a force displacement transducer (UF1 Pioden Controls, Paris, France) connected to the upper hook.
Tensions were recorded on a Servo trace recorder (Sefram, Paris). During the equilibration period of 60 min, the buffer was changed every 15 min and resting tension was adjusted periodically to 1.5 g. Active contraction was induced with KCl 40 mmol litre 91 and the integrity of endothelium was assessed by testing the relaxation produced by the addition of acetylcholine 10
96 mol litre
91
. 20 Endothelium was considered intact when acetylcholine elicited a minimum of 30% vasodilatation. Endothelium was considered removed when acetylcholine induced no vasodilatation. After acetylcholine testing, the rings were washed and re-equilibrated to baseline tension for 60 min. After this new period of stability, rings were constricted with KCl 40 mmol litre 91 or phenylephrine 10 96 mol litre
. Isoflurane was then delivered using a calibrated agent-specific vaporizer (Abbott, France). The concentrations of isoflurane in the gas phase were monitored and adjusted using an anaesthetic agent monitor. Aortic rings were exposed to cumulative concentrations of isoflurane of 1-5%. Each concentrations was maintained until the effect on the aortic ring reached a plateau (i.e. an average of 10 min). The vasodilator effect of isoflurane was expressed as percentage decrease in tension compared with the plateau reached after KCl or phenylephrine.
ROLE OF ENDOTHELIUM AND ENDOTHELIUM-DERIVED NITRIC OXIDE, PROSTANOIDS, EDHF AND ENDOTHELINS IN ISOFLURANE-INDUCED VASODILATATION
The role of endothelium was assessed by comparing isoflurane-induced vasodilatation between intact and denuded rings. To assess the role of EDHF in the relaxation of intact and denuded rings, the experiment was conducted in phenylephrine preconstricted rings (intact rings n:12, denuded rings n:12), and in KCl (which inhibits EDHF) 21 preconstricted rings (intact rings n:12, denuded rings n:12).
The role of nitric oxide was assessed in KClpreconstricted vessels by comparing isofluraneinduced vasodilatation between intact rings (n:12) and rings incubated with an inhibitor of endothelial nitric oxide synthase, N-nitro-L-arginine (LNNA) 5 10 95 mol litre 91 (n:12). The role of prostanoids was assessed in KClpreconstricted vessels by comparing isofluraneinduced vasodilatation between intact rings (n:12) and rings incubated with an inhibitor of cyclooxygenase, indomethacin 10 
Results
Isoflurane produced dose-dependent relaxation in all groups of rings.
In KCl-preconstricted vessels, isoflurane-induced relaxation was significantly greater in denuded than (4) 73 (2) 81 (2) in intact rings at concentrations of 4% and 5% (table  1) . In phenylephrine-constricted vessels, isofluraneinduced relaxation was significantly greater in denuded than in intact rings at concentrations of 4% and 5% (table 2) . The difference in vasodilatation between intact and denuded rings was comparable between vessels constricted with phenylephrine and vessels constricted with KCl at 4% isoflurane (23 (4) % vs 19 (2) %; ns) and at 5% isoflurane (20 (3) % vs 29 (3) %; ns). Isoflurane-induced relaxation was significantly greater in rings treated with LNNA than in intact rings at concentrations of 4% and 5% and was comparable with relaxation obtained in denuded rings (table 1) .
Relaxations were not significantly different between intact rings and rings treated with BQ 123 or indomethacin (table 1) .
Discussion
We have shown that isoflurane dose dependently relaxed aortic rings via an endothelium-independent mechanism 1-7 as vasodilatation obtained in intact vessels was present in vessels without endothelium. However, we found that the presence of endothelium modified the response to isoflurane, as denuded vessels were relaxed more than intact vessels.
The fact that vasodilatation was greater in denuded than in intact vessels suggests that isoflurane may have altered endothelial control of vascular tone. To explain such an effect, we hypothesized that isoflurane may either decrease release of endothelium-derived relaxing factors or increase release of endothelium-derived contracting factors 4 7 : of the endothelium-derived relaxing substances, we examined nitric oxide, EDHF and prostacyclin; of the endothelium-derived constricting factors, we examined endothelins and thromboxane A 2 .
Nitric oxide is a labile molecule synthesized by endothelium which relaxes vessels by increasing the concentration of 3' 5'-guanosine monophosphate (cGMP) within the vasculature 24 and by hyperpolarizing smooth muscle cells. 25 To assess the role of nitric oxide, we have compared the effect of isoflurane between intact rings and rings incubated with LNNA. We found that vessels treated with LNNA relaxed more than intact rings. This indicates that nitric oxide did not mediate isoflurane-induced vasodilatation but rather modulated this effect. Indeed, if nitric oxide has a role in isofluraneinduced vasodilatation, vessels treated with LNNA should dilate less than intact vessels, and not the contrary. Therefore, we suggest that the fact that relaxation was less in intact compared with LNNAtreated vessels was possibly a result of inhibition of release of nitric oxide by isoflurane. This hypothesis is supported by the study of Brendel and Johns, 7 who showed similar results in the aorta, and by studies which demonstrated that volatile anaesthetics decreased the amount of nitric oxide produced by endothelial cells. The mechanisms involved in this attenuation produced by nitric oxide do not involve smooth muscle cell hyperpolarization as similar results were obtained in the presence of KCl, which inhibits hyperpolarization. 25 Isoflurane-induced decrease in production or stability of nitric oxide 15 may lead to a relative vasoconstriction counterbalancing the relaxation produced by isoflurane.
The effects of endothelium-derived hyperpolarizing factors (EDHF) are not well understood but a vasodilator action has been documented. 26 To assess the role of EDHF in the difference in relaxation between intact and denuded rings, experiments were conducted in vessels constricted with phenylephrine and KCl, which are known to inhibit the action of EDHF. 21 We found that the difference in relaxation between intact and denuded rings persisted in the absence of EDHF. Therefore, we conclude that EDHF did not play a role in modulating isoflurane-induced vasodilatation.
Prostanoids are end products of arachidonic acid metabolism and are synthesized by endothelium via activation of cyclo-oxygenase. 27 Prostacyclin is a vasodilator while thromboxane A 2 is a vasoconstrictor. 27 To assess the role of prostanoids in the difference in relaxation between intact and denuded rings, the effect of isoflurane was compared between intact rings and rings incubated with indomethacin. We found that relaxation in rings treated with indomethacin was comparable with that of intact vessels. Therefore, modulation of isoflurane-induced vasodilatation was not mediated by release of a contracting prostanoid or by inhibition of the release of a relaxing factor.
Endothelins are peptides synthesized by endothelium that act on adjacent smooth muscle cells to produce vasoconstriction. 22 This effect is mediated via activation of specific receptors (ET-A receptors). 22 23 As the difference in relaxation between intact and denuded rings may result from increased production of endothelins, we compared the effect of isoflurane on intact rings and rings incubated with BQ 123, a specific antagonist of ET-A receptors. 23 We found that relaxation of rings treated with BQ 123 was comparable with that in intact rings. Therefore, endothelins do not play a role in modulating isoflurane-induced vasodilatation. 
